Trial of Adjuvant Gemcitabine for Pancreatic Cancer: The Jury Is Still Out

Publisher： Karger

E-ISSN： 1424-3911|7|5-6|548-549

ISSN： 1424-3903

Source： Pancreatology, Vol.7, Iss.5-6, 2007-09, pp. : 548-549

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Nicotinamide and skin cancer chemoprevention: The jury is still out

By  

AUSTRALASIAN JOURNAL OF DERMATOLOGY, Vol. 59, Iss. 1, 2018-02 ,pp. : 6-9

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized clinical trial of adjuvant chemotherapy with S‐1 versus gemcitabine after pancreatic cancer resection

By  

BRITISH JOURNAL OF SURGERY, Vol. 102, Iss. 7, 2015-06 ,pp. : 746-754

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer

By  

BRITISH JOURNAL OF SURGERY, Vol. 105, Iss. 3, 2018-02 ,pp. : 192-202

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gemcitabine: Progress in the Treatment of Pancreatic Cancer

By  

Oncology, Vol. 60, Iss. 1, 2000-12 ,pp. : 8-18

Karger

Access to resources Recommend Favorite

Phase I Trial of Gemcitabine Dose Escalation with Concurrent Radiotherapy for Patients with Locally Advanced Pancreatic Cancer

By  

Pancreatology, Vol. 10, Iss. 1, 2010-03 ,pp. : 60-65

Karger

Access to resources Recommend Favorite